Skip NavigationSkip to Content

Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluation

  1. Author:
    Romagnoli, R.
    Baraldi, P. G.
    Carrion, M. D.
    Cruz-Lopez, O.
    Cara, C. L.
    Balzarini, J.
    Hamel, E.
    Canella, A.
    Fabbri, E.
    Gambari, R.
    Basso, G.
    Viola, G.
  2. Author Address

    Romagnoli, Romeo, Baraldi, Pier Giovanni, Carrion, Maria Dora, Cruz-Lopez, Olga, Cara, Carlota Lopez] Univ Ferrara, Dipartimento Sci Farmaceut, I-44100 Ferrara, Italy. [Balzarini, Jan] Rega Inst, Lab Virol & Chemotherapy, B-3000 Louvain, Belgium. [Hamel, Ernest] NCI, NIH, Div Canc Treatment & Diag, Toxicol & Pharmacol Branch,Dev Therapeut Program, Frederick, MD 21702 USA. [Canella, Alessandro, Fabbri, Enrica, Gambari, Roberto] Univ Ferrara, Dipartmento Biochim & Biol Mol, I-44100 Ferrara, Italy. [Basso, Giuseppe, Viola, Giampietro] Univ Padua, Lab Oncoematol, Dipartimento Pediat, I-35131 Padua, Italy.
    1. Year: 2009
  1. Journal: Bioorganic & Medicinal Chemistry Letters
    1. 19
    2. 7
    3. Pages: 2022-2028
  2. Type of Article: Article
  1. Abstract:

    Research into the anti-tumor properties of chalcones has received significant attention over the last few years Two novel large series of alpha-bromoacryloylamido chalcones 1a-m and 2a-k containing a pair of Michael acceptors in their structures, corresponding to the alpha-bromoacryloyl moiety and the alpha,beta-unsaturated ketone system of the chalcone framework, were synthesized and evaluated for antiproliferative activity against five cancer cell lines. Such hybrid derivatives demonstrated significantly increased anti-tumor activity compared with the corresponding amino chalcones. The most promising lead molecules were 1k, 1m and 2j, which had the highest activity toward the five cell lines. Flow cytometry with K562 cells showed that the most active compounds resulted in a large proportion of the cells entering in the apoptotic sub-G0-G1 peak. Moreover, compound 1k induced apoptosis through the mitochondrial pathway and activated caspase-3. (C) 2009 Elsevier Ltd. All rights reserved.

    See More

External Sources

  1. PMID: 19250822

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel